Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-24-008 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support product-focused research to advance controlled release vaccine strategies to improve immune responses for HIV prevention, treatment, and cure and develop simplified or single-shot vaccination formulations. Timelines with measurable milestones are required. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 27, 2024 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Research to Stimulate Development of Diagnostics, Therapeutics, and Vaccines for Herpes Simplex Virus (HSV)
Notice NOT-AI-24-028 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 27, 2024 Category: Research Source Type: funding
Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-24-112 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support research that improves understanding of basic mechanisms and biomarkers of trained immunity (i.e., innate immune memory), plus the functional implications of trained immunity, related to 1) immune system development and function, 2) immunity to vaccines or natural infections, or 3) allergic diseases, autoimmunity, or rejection of organ/tissue/cell transplantation. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 25, 2024 Category: Research Source Type: funding
Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-24-111 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support research that improves understanding of basic mechanisms and biomarkers of trained immunity (i.e., innate immune memory), plus the functional implications of trained immunity, related to 1) immune system development and function, 2) immunity to vaccines or natural infections, or 3) allergic diseases, autoimmunity, or rejection of organ/tissue/cell transplantation. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 25, 2024 Category: Research Source Type: funding
Research Initiative for Vaccine and Antibiotic Allergy (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-24-002 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support research that enhances understanding of the mechanisms and management of vaccine and antibiotic drug allergy. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2023 Category: Research Source Type: funding
Pre-Solicitation Notice: Humoral Immunology Core Laboratory for AIDS Vaccine Research, RFP: 75N93023R00012
Notice NOT-AI-24-005 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 17, 2023 Category: Research Source Type: funding
Notice of Change to Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed), PAR-23-033
Notice NOT-AI-24-004 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 8, 2023 Category: Research Source Type: funding
NIHB Vaccination Event Funding
Funding for tribal health organizations to host COVID-19 vaccination events. Geographic coverage: Nationwide -- National Indian Health Board (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - October 19, 2023 Category: American Health Source Type: funding
Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional)
Funding Opportunity RFA-CA-24-006 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity Announcement (NOFO), the National Cancer Institute (NCI) intends to expand the research scope and leverage the gains made through the NOFO entitled Investigation of the Transmission of KSHV (RFA-CA-18-013 and RFA-CA-20-046) to support basic and translational research that will guide the development of a prophylactic or therapeutic Kaposi sarcoma herpesvirus (KSHV) vaccine. A prophylactic KSHV vaccine could prevent primary KSHV infection, transmission, and subsequent development of KS and other KSHV-a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 16, 2023 Category: Research Source Type: funding
Notice of Information: Request for Information (RFI) for Development of Vaccine Candidates for Biodefense, Antimicrobial Resistant (AMR) Infections, and Emerging Infectious Diseases, HHS-NIH-NIAID-BAA2024-1 Available in Sam.gov
Notice NOT-AI-24-001 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 12, 2023 Category: Research Source Type: funding
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
Funding Opportunity PAR-24-037 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive evaluation of vaccine concepts in non-human primate models may be included. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 4, 2023 Category: Research Source Type: funding
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-23-054 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support basic research that will elucidate mechanisms of Fc-mediated antibody functions, including antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cell-mediated phagocytosis (ADCP). Supported studies are expected to generate foundational data and tools that can be applied to the prediction of Fc-mediated killing activity by antibodies. Such data should accelerate development of therapeutic monoclonal antibodies and design of vaccines or vaccine-adjuvant comb...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 26, 2023 Category: Research Source Type: funding
Minnesota Mpox Prevention Funding
Funding to make mpox services more available to decrease mpox transmission and increase mpox vaccination and education, particularly in individuals and communities with the highest rates of new diagnoses. Funds may also be used to maintain or expand outbreak response activities into sustainable programs to prevent future outbreaks. Geographic coverage: Minnesota -- Minnesota Department of Health (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - September 13, 2023 Category: American Health Source Type: funding
Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-23-056 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for the Computational Models of Influenza Immunity Cooperative Agreement Program. The program will employ computational modeling and immunologic studies to advance our understanding of the requirements for improving anti-influenza immunity, including inducing broad immune protection and enhancing immune durability. This program will help inform design of universal or improved seasonal flu vaccines. Projects may lead to a better understanding of how pre-existing immunity and repeat...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 13, 2023 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Promoting Research and Development of Vaccines Against Enteric Viruses
Notice NOT-AI-23-048 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 15, 2023 Category: Research Source Type: funding
